Quarterly report · Q2
7317.TEDINET S100S79V
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥7.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥617m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥202m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥619m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥675m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥291m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥619m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥291m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥437m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥205m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥437m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥205m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥9.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.8bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥262m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥915m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥33m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥546m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥648m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥146m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥20.67 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.75 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.17 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.7 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.42 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥20.43 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥20.02 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥9.63 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 48.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥23m |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥23m |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥147m |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥693m |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥62m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.2bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.2bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥763m |
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥8m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥8m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥125m |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥413m |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥836m |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥836m |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥82m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥327m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 462
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred tax liabilities | Prior1YearInstant | 7399000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 48511000 | JPY |
| Other ncl | Prior1YearInstant | 386991000 | JPY |
| Other ncl | CurrentQuarterInstant | 269583000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 548098000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1982824000 | JPY |
| Liabilities | Prior1YearInstant | 4968391000 | JPY |
| Liabilities | CurrentQuarterInstant | 5056160000 | JPY |
| Capital stock | Prior1YearInstant | 308772000 | JPY |
| Capital stock | CurrentQuarterInstant | 15779000 | JPY |
| Capital surplus | Prior1YearInstant | 201124000 | JPY |
| Capital surplus | CurrentQuarterInstant | 505676000 | JPY |
| Retained earnings | Prior1YearInstant | 3068172000 | JPY |
| Retained earnings | CurrentQuarterInstant | 3478875000 | JPY |
| Treasury stock | Prior1YearInstant | -479000 | JPY |
| Treasury stock | CurrentQuarterInstant | -479000 | JPY |
| Shareholders equity | Prior1YearInstant | 3577590000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 3999852000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 197556000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 661892000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 197556000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 661892000 | JPY |
| Net assets | Prior1YearInstant | 3775147000 | JPY |
| Net assets | CurrentQuarterInstant | 4661745000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 8743538000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 9717906000 | JPY |
| Net sales | Prior1YTDDuration | 2872997000 | JPY |
| Net sales | CurrentYTDDuration | 4162857000 | JPY |
| Cost of sales | Prior1YTDDuration | 2259078000 | JPY |
| Cost of sales | CurrentYTDDuration | 3067469000 | JPY |
| Gross profit | Prior1YTDDuration | 613918000 | JPY |
| Gross profit | CurrentYTDDuration | 1095387000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 411567000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 478812000 | JPY |
| Operating income | Prior1YTDDuration | 202351000 | JPY |
| Operating income | CurrentYTDDuration | 616575000 | JPY |
| Interest income noi | Prior1YTDDuration | 1337000 | JPY |
| Interest income noi | CurrentYTDDuration | 1662000 | JPY |
| Dividends income noi | Prior1YTDDuration | 0 | JPY |
| Dividends income noi | CurrentYTDDuration | 0 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 100539000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 34414000 | JPY |
| Other noi | Prior1YTDDuration | 8944000 | JPY |
| Other noi | CurrentYTDDuration | 1986000 | JPY |
| Non operating income | Prior1YTDDuration | 110822000 | JPY |
| Non operating income | CurrentYTDDuration | 38064000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 22431000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 18513000 | JPY |
| Factory relocation expenses noe | Prior1YTDDuration | - | JPY |
| Factory relocation expenses noe | CurrentYTDDuration | 15749000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |